Overview of the 2022 WHO classification of thyroid neoplasms

ZW Baloch, SL Asa, JA Barletta, RA Ghossein… - Endocrine …, 2022 - Springer
This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

[HTML][HTML] Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach

CK Jung, A Bychkov, K Kakudo - Endocrinology and …, 2022 - synapse.koreamed.org
The fifth edition of the World Health Organization (WHO) histologic classification of thyroid
neoplasms released in 2022 includes newly recognized tumor types, subtypes, and a …

Thyroid cancer, recent advances in diagnosis and therapy

F Nabhan, PH Dedhia… - International journal of …, 2021 - Wiley Online Library
Over the past several decades, the approach to the diagnosis and management of patients
with follicular cell‐derived thyroid cancer has evolved based on improved classification of …

Change in diagnostic criteria for noninvasive follicular thyroid neoplasm with papillarylike nuclear features

YE Nikiforov, ZW Baloch, SP Hodak, TJ Giordano… - JAMA …, 2018 - jamanetwork.com
Methods| We reviewed English-language publications through PubMed (January 24, 2018),
using a keyword search for NIFTP. We focused on large patient cohorts with tumors meeting …

[HTML][HTML] Thyroseq v3, Afirma GSC, and microRNA panels versus previous molecular tests in the preoperative diagnosis of indeterminate thyroid nodules: a systematic …

CA Silaghi, V Lozovanu, CE Georgescu… - Frontiers in …, 2021 - frontiersin.org
Background Molecular tests are being used increasingly as an auxiliary diagnostic tool so
as to avoid a diagnostic surgery approach for cytologically indeterminate thyroid nodules …

Heterogeneity of thyroid cancer

E Chmielik, D Rusinek, M Oczko-Wojciechowska… - Pathobiology, 2018 - karger.com
There are 5 main histological types of thyroid cancers (TCs): papillary, follicular (also known
as differentiated), poorly differentiated, anaplastic (the most aggressive form), and medullary …

[HTML][HTML] Significance of RAS mutations in thyroid benign nodules and non-medullary thyroid cancer

V Marotta, M Bifulco, M Vitale - Cancers, 2021 - mdpi.com
Simple Summary Only about 4% of thyroid nodules are carcinomas and require surgery.
Fine-needle aspiration cytology is the most accurate tool to distinguish benign from …

[HTML][HTML] Updates in the pathologic classification of thyroid neoplasms: a review of the World Health Organization classification

Y Bai, K Kakudo, CK Jung - Endocrinology and Metabolism, 2020 - synapse.koreamed.org
Advances in medical sciences and evidence-based medicine have led to momentous
changes in classification and management of thyroid neoplasms. Much progress has been …

Follow-up of differentiated thyroid cancer–what should (and what should not) be done

L Lamartina, G Grani, C Durante, I Borget… - Nature Reviews …, 2018 - nature.com
The treatment paradigm for thyroid cancer has shifted from a one-size-fits-all approach to
more personalized protocols that range from active surveillance to total thyroidectomy …

Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign?

DN Parente, WP Kluijfhout, PJ Bongers… - World Journal of …, 2018 - Wiley Online Library
Background Renaming encapsulated follicular variant of papillary thyroid carcinoma
(EFVPTC) to noninvasive follicular thyroid neoplasm with papillary‐like nuclear features …